Another COVID-19 vaccine developed in Massachusetts entering Phase 3 trial

After months of laboratory work and successful testing in rhesus macaque monkeys, researchers at Johnson & Johnson and Beth Israel Deaconess Medical center are now looking for 60,000 people to participate in Phase 3 trials. Read Article